文献速递心外重症与机械循环支持先天性心脏病外科

儿童机械循环支持装置PediaFlow心室辅助装置的临床前性能研究

Preclinical performance of a pediatric mechanical circulatory support device: The PediaFlow ventricular assist device.
PubMed 文献 · J Thorac Cardiovasc Surg · 2018-04-21

PediaFlow是一种微型植入式全磁悬浮连续流儿童心室辅助装置,第四代产品在体外及绵羊临床前模型(n=11)中评估性能与生物相容性,植入设计在最近2例植入中体现。装置运行范围0.5至1.5 L/min,体外溶血轻微,体内血液相容性良好,最终组件支持长达60天的儿童应用血流动力学。

要点

  • 第四代PediaFlow运行范围0.5至1.5 L/min,体外溶血轻微、体内血液相容性良好。
  • 泵及最终植入组件在临床前显示适合儿童应用的血流动力学,支持长达60天。
  • 美国食品药品监督管理局授予该装置人道主义使用设备资格,用于体重不超过20 kg新生儿的机械循环支持。

核心结论

  • 第四代PediaFlow的初步结果记录了其生物相容性以及提供慢性儿童心脏支持的潜力。

研究设计与样本

  • 由匹兹堡大学领导的联盟在体外及绵羊临床前模型(n=11)中评估第四代PediaFlow原型。
  • 上述实验导致流入插管和流出移植血管多次重新设计,最终形成最近植入(n=2)中使用的可植入设计。

主要发现

  • 经过十余年涵盖4个装置迭代的计算与实验工作,AA电池大小的第四代PediaFlow运行范围为0.5至1.5 L/min。
  • 体外溶血轻微,体内血液相容性良好(例如溶血和血小板活化轻微)。
  • 泵及最终配套植入组件在临床前显示适合预期儿童应用的血流动力学,支持长达60天。

关键数值与推荐

  • 美国食品药品监督管理局将该装置指定为人道主义使用设备,用于体重不超过20 kg的新生儿、婴儿和幼儿的机械循环支持,作为移植桥、其他治疗干预(如手术)桥或恢复桥。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The PediaFlow (HeartWare International, Inc, Framingham, Mass) is a miniature, implantable, rotodynamic, fully magnetically levitated, continuous-flow pediatric ventricular assist device. The fourth-generation PediaFlow was evaluated in vitro and in vivo to characterize performance and biocompatibility. METHODS: Supported by 2 National Heart, Lung, and Blood Institute contract initiatives to address the limited options available for pediatric patients with congenital or acquired cardiac disease, the PediaFlow was developed with the intent to provide chronic cardiac support for infants as small as 3 kg. The University of Pittsburgh-led Consortium evaluated fourth-generation PediaFlow prototypes both in vitro and within a preclinical ovine model (n = 11). The latter experiments led to multiple redesigns of the inflow cannula and outflow graft, resulting in the implantable design represented in the most recent implants (n = 2). RESULTS: With more than a decade of extensive computational and experimental efforts spanning 4 device iterations, the AA battery-sized fourth-generation PediaFlow has an operating range of 0.5 to 1.5 L/min with minimal hemolysis in vitro and excellent hemocompatibility (eg, minimal hemolysis and platelet activation) in vivo. The pump and finalized accompanying implantable components demonstrated preclinical hemodynamics suitable for the intended pediatric application for up to 60 days. CONCLUSIONS: Designated a Humanitarian Use Device for "mechanical circulatory support in neonates, infants, and toddlers weighing up to 20 kg as a bridge to transplant, a bridge to other therapeutic intervention such as surgery, or as a bridge to recovery" by the Food and Drug Administration, these initial results document the biocompatibility and potential of the fourth-generation PediaFlow design to provide chronic pediatric cardiac support.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Olia SE, Wearden PD, Maul TM, et al. Preclinical performance of a pediatric mechanical circulatory support device: The PediaFlow ventricular assist device. J Thorac Cardiovasc Surg. 2018. PMID: 29807773. doi:10.1016/j.jtcvs.2018.04.062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。